
Sign up to save your podcasts
Or


This week we're musing about the sad fate of NFTs, the race to build AI co-pilots, Neuralink human trials, and the new Caleb Wood GenAI Star Wars fan scene. Our guest is Michael Freeman, co-founder of Ocutrx, which is launching an AR HMD, the Oculenz, that will help macular degeneration patients see.
Thank you to our sponsor, Zappar!
Don't forget to like, share, and follow for more! Follow us on all socials @ThisWeekInXR!
https://linktr.ee/thisweekinxr
Hosted on Acast. See acast.com/privacy for more information.
By Charlie Fink Productions4.8
1919 ratings
This week we're musing about the sad fate of NFTs, the race to build AI co-pilots, Neuralink human trials, and the new Caleb Wood GenAI Star Wars fan scene. Our guest is Michael Freeman, co-founder of Ocutrx, which is launching an AR HMD, the Oculenz, that will help macular degeneration patients see.
Thank you to our sponsor, Zappar!
Don't forget to like, share, and follow for more! Follow us on all socials @ThisWeekInXR!
https://linktr.ee/thisweekinxr
Hosted on Acast. See acast.com/privacy for more information.

43,557 Listeners

665 Listeners

1,081 Listeners

3,146 Listeners

22 Listeners

232 Listeners

47 Listeners

365 Listeners

488 Listeners

705 Listeners

209 Listeners

560 Listeners

7 Listeners

0 Listeners